Restoring Insulin Secretion Pediatric Medication Study
Phase of Trial: Phase III
Latest Information Update: 15 Oct 2018
At a glance
- Drugs Insulin glargine (Primary) ; Metformin (Primary)
- Indications Prediabetic-state; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms RISE Peds
- 01 Oct 2018 Status changed from active, no longer recruiting to completed.
- 25 Jun 2018 Primary endpoint (B-cell function measured by hyperglycemic clamp techniques: clamp-derived steady-state C-peptide and ACPRmax at 15 months (both evaluated jointly with M/I; co-primary outcomes)) has not been met, according to results published in the Diabetes Care Journal.
- 25 Jun 2018 According to results published in the Diabetes Care Journal, this trial was trial funded by the National Institute of Diabetes and Digestive and Kidney Diseases.